We provide reliable and scientifically robust virtual screening to identify potential lead compounds efficiently and cost-effectively.

Our virtual screening workflows combine structure-based and ligand-based approaches to prioritize compounds based on binding affinity, drug-likeness, and relevance to your biological target, supporting early-stage drug discovery.

What We Offer

• Structure-based and ligand-based virtual screening
• Molecular docking and scoring
• Compound library preparation and filtering
• Hit identification and prioritization
• Drug-likeness and basic ADMET filtering
• Result interpretation and report-ready outputs